Millennium Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$831K Sell
59,436
-238,530
-80% -$3.33M ﹤0.01% 3123
2025
Q1
$4.02M Sell
297,966
-68,006
-19% -$917K ﹤0.01% 2113
2024
Q4
$7.02M Sell
365,972
-302,064
-45% -$5.79M ﹤0.01% 1795
2024
Q3
$15.2M Buy
668,036
+439,854
+193% +$10M 0.01% 1279
2024
Q2
$2.97M Buy
228,182
+207,711
+1,015% +$2.7M ﹤0.01% 2240
2024
Q1
$358K Sell
20,471
-204,318
-91% -$3.58M ﹤0.01% 3438
2023
Q4
$4.9M Sell
224,789
-1,155,861
-84% -$25.2M ﹤0.01% 1914
2023
Q3
$21.2M Buy
1,380,650
+42,862
+3% +$658K 0.01% 935
2023
Q2
$31.8M Buy
1,337,788
+723,699
+118% +$17.2M 0.02% 732
2023
Q1
$15.6M Sell
614,089
-171,765
-22% -$4.37M 0.01% 1112
2022
Q4
$23M Buy
785,854
+23,794
+3% +$695K 0.01% 913
2022
Q3
$15.6M Sell
762,060
-364,025
-32% -$7.47M 0.01% 1123
2022
Q2
$13M Buy
1,126,085
+150,467
+15% +$1.74M 0.01% 1264
2022
Q1
$18M Buy
975,618
+513,228
+111% +$9.49M 0.01% 1052
2021
Q4
$9.14M Buy
462,390
+301,045
+187% +$5.95M ﹤0.01% 1662
2021
Q3
$2.65M Buy
161,345
+43,630
+37% +$718K ﹤0.01% 2778
2021
Q2
$2.15M Buy
117,715
+74,539
+173% +$1.36M ﹤0.01% 3079
2021
Q1
$721K Buy
+43,176
New +$721K ﹤0.01% 3438
2020
Q2
Sell
-916
Closed -$6K 3779
2020
Q1
$6K Sell
916
-11,077
-92% -$72.6K ﹤0.01% 3085
2019
Q4
$86K Sell
11,993
-14,724
-55% -$106K ﹤0.01% 3324
2019
Q3
$292K Sell
26,717
-12,947
-33% -$142K ﹤0.01% 2975
2019
Q2
$1.22M Buy
39,664
+34,984
+748% +$1.08M ﹤0.01% 2261
2019
Q1
$196K Buy
+4,680
New +$196K ﹤0.01% 3204
2018
Q4
Sell
-5,916
Closed -$495K 3727
2018
Q3
$495K Sell
5,916
-1,962
-25% -$164K ﹤0.01% 2894
2018
Q2
$758K Buy
7,878
+3,991
+103% +$384K ﹤0.01% 2637
2018
Q1
$409K Buy
+3,887
New +$409K ﹤0.01% 2858
2017
Q2
Sell
-4,347
Closed -$811K 3582
2017
Q1
$811K Buy
+4,347
New +$811K ﹤0.01% 2314